These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39327249)

  • 1. KLHDC8A Regulates M1/M2 Macrophage Polarization Through the PD-1/STAT3 Pathway to Promote Papillary Thyroid Cancer Development.
    Peng Y; Wen M; Yu J; He C; Yu J
    Discov Med; 2024 Sep; 36(188):1858-1868. PubMed ID: 39327249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE expression in papillary thyroid carcinoma: Influencing tumor progression and macrophage polarization.
    Huo R; Zhao R; Li Z; Li M; Bin Y; Wang D; Xue G; Wu J; Lin X
    Immunobiology; 2024 Sep; 229(5):152821. PubMed ID: 38935988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 promotes migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma by activating STAT3 signaling pathway.
    Hu Y; Xu Z; Zhou D; Hou H; Liu B; Long H; Hu W; Tang Y; Wang J; Wei D; Zhao Q
    J Cancer Res Ther; 2024 Aug; 20(4):1241-1250. PubMed ID: 39206986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
    Gao H; Sun X; Wang H; Zheng Y
    Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKS1B promotes cell proliferation and invasion by activating STAT3/PD-L1 and phosphorylation of Akt signaling in papillary thyroid carcinoma.
    Wang H; Zhang Z; Yan Z; Ma S
    J Clin Lab Anal; 2021 Jan; 35(1):e23565. PubMed ID: 32960462
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Liu W; Lin R; Zhu C; Chen Y; Gao Q; Zhong J
    Discov Med; 2024 Sep; 36(188):1819-1830. PubMed ID: 39327245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
    Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
    Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 1 promotes proliferation and invasion of papillary thyroid cancer through the STAT3 pathway.
    Yang L; Tan Z; Li Y; Zhang X; Wu Y; Xu B; Wang M
    J Clin Lab Anal; 2020 Dec; 34(12):e23531. PubMed ID: 32851683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
    Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
    Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
    Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.
    Chi J; Liu Y; Yang L; Yang J
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1408-1423. PubMed ID: 35568099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cep63 knockout inhibits the malignant phenotypes of papillary thyroid cancer cell line TPC‑1.
    Liu C; Yu F; Ma R; Zhang L; Du G; Niu D; Yin D
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis.
    Sun Z; Guo X; Zang M; Wang P; Xue S; Chen G
    J Cell Physiol; 2019 Feb; 234(2):1336-1345. PubMed ID: 30146756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
    Bi CL; Zhang YQ; Li B; Guo M; Fu YL
    J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
    Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z
    Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.